Explore Big Pharma’s M&A trends, their impact on supply chains, and the urgent need for adaptability in a rapidly evolving healthcare landscape However, researching partnerships, acquisitions, and divestments made by large multinational firms over time reveals trends and evolutionary patterns in the ecosystem. In this article, I will consider some mergers and acquisitions transactions to extrapolate how life sciences will change shortly. I will start by exploring the information available in the last decade’s financial statements of large life science firms to gain a quantitative idea of how serious they have been around the change. I will end by exploring the potential implications of these…...
Fast M&A, Furious Supply Chains: Pharma’s Race for Resilience
6 min read